By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelr8 said that it has signed a technology evaluation agreement with an unnamed global diagnostic company for its BACcel system.

Accelr8 said that the deal includes an option to license the system and develop diagnostic products based on the technology. The firm said that it will receive an initial payment plus additional payments based on completion of data evaluation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.